Your English writing platform
Discover LudwigSuggestions(5)
Exact(19)
Seventh, a randomized open-label study comparing long-acting with short-acting methylphenidate reported a number-needed-to-treat (NNT) of 3.6 to 4.8 to achieve one additional responder (depending on response criterion applied), consistently below the NNTs synthesized for assessment (TAR, pp. 226ff).
This placebo treatment continued for one or 2 days, depending on response to treatment.
In addition, group one was given meloxicam (Metacam, 5 mg/ml, Boehringer Ingelheim Vetmedica GmbH, Binger Straße 173, 55216 Ingelheim am Rhein, Germany), subcutaneously, at standard dosage of 0.2 mg/kg on day one, followed by oral treatment (Metacam oral suspension 1.5 mg/ml) at standard dosage of 0.1 mg/kg for the following one or 2 days, depending on response to treatment.
Further therapeutic trials were carried out depending on response to treatment and the possible differential diagnoses.
All patients underwent WBRT (23.4 vs. 45 Gy depending on response to induction) followed by cytarabine.
Treatment was repeated every 4 weeks up to six courses depending on response.
Similar(41)
Depending on responses, children were assigned to three groups (low, intermediate, and high FAS level).
Thus, one way in which a problem may become more difficult is if its solution depends on response to more subtle changes in stimuli.
We propose that attentional modulations in visual cortex depend on response normalization mechanisms, and have presented a basic attentional normalization model to demonstrate the feasibility of this idea.
As a consequence, the reliability and validity of course ratings would depend on response rates.
Decisions on which survey mode to use depend on response rates, response bias, item non-response and costs.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com